© 2002 by Heart
VIEWPOINT
NICE: guessing is not guidance
Correspondence to:
Correspondence to:
Professor Poole-Wilson, Cardiac Medicine, National Heart and Lung Institute, Imperial College School of Medicine, Imperial College, Dovehouse Street, London SW3 6LY, UK;
p.poole-wilson{at}ic.ac.uk
A preliminary assessment of the extent to which the National Institute for Clinical Excellence (NICE) has achieved its goals within cardiovascular medicine is presented. NICE is a government sponsored agency operating in the UK which attempts to assess the value of medical therapies, devices, and surgery for a wide range of medical and surgical problems. Its recommendations determine whether a particular therapy can be adopted in the National Health Service.
Keywords: National Institute for Clinical Evidence; stents; implantable cardioverter-defibrillators; glycoprotein IIb/IIIa inhibitors
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Henry, D. A., Hill, S. R., Harris, A.
(2005). Drug Prices and Value for Money: The Australian Pharmaceutical Benefits Scheme. JAMA
294: 2630-2632
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
